Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 38 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
NCT07082868
- Conditions
- Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma (PCNSL), +4 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
NCT05351593
- Conditions
- CNS Lymphoma, Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Conditions
- PCNSL, Primary Central Nervous System Lymphoma
- Locations
-
- The First Affiliated Hospital of Fujian Medical University Xiamen, Fujian, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
- China-Japan Union Hospital of Jilin University Changchun, Jilin, China
- Shanxi Provincial People's Hospital Taiyuan, Shanxi, China
NCT05681195
- Conditions
- Disease Attributes, Neoplasms, Pathologic Processes, +6 more
- Locations
-
- Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
NCT04421560
- Conditions
- Disease Attributes, Neoplasms, Pathologic Processes, +6 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Columbia University Medical Center New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT06475235
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06712810
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04906096
- Conditions
- Non-Hodgkin Lymphoma of Extranodal Site, Primary Central Nervous System Lymphoma
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06175000
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- Cleveland Clinic Cleveland, Ohio, United States
- Providence Health & Services; Providence Neurological Specialties Portland, Oregon, United States
- Pennsylvania State University Hershey, Pennsylvania, United States
NCT04737889
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China
NCT06940791
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Kyorin University Hospital Tokyo, Japan
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
NCT06832267
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT06830421
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- University Hospital Freiburg, Department Medicine I, Hematology, oncology and stem cell transplantation Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl Stuttgart, Baden-Wurttemberg, Germany
- University Hospital Aachen Aachen, Germany
- University Hospital Augsburg Augsburg, Germany
NCT04070040
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Sanbo Brain Hospital Capital Medical University Beijing, China
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
NCT05600660
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hanzhou, Zhejiang, China
Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
NCT02836158
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Navy General Hospital Beijing, Beijing Municipality, China
NCT02657785
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Navy General Hospital Beijing, Beijing Municipality, China
Methotrexate Early Toxicity Monitoring
NCT07406230
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Assistance Publique - Hôpitaux de Marseille Marseille, France
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
NCT07185373
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- West China Hospital of Sichuan University Chengdu, China
- Department of Hematology, Qilu Hospital of Shandong University Jinan, China
Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
NCT05347641
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
Not specified